WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) today will be hosting an Analyst Day to provide an update for the investment community on the company’s commercial strategy, select late and early-stage clinical development programs, as well as the revitalization of its research organization. The event will be led by George A. Scangos, Ph.D., Chief Executive Officer, Tony Kingsley, Executive Vice President of Global Commercial Operations, and Douglas Williams, Executive Vice President of Research and Development (R&D), along with other members of the company scientific leadership team.
